Learn More
CERILLIANT™ Lisdexamfetamine-D4 dimesylate Solution, 100 μg/mL in Methanol (as free base), Sold by MilliporeSigma™ Supelco™
Certified reference material
Supplier: MilliporeSigma Supelco L0281ML
Description
A certified solution standard suitable for quantitation of lisdexamfetamine in urine or other biological samples by GC/MS or LC/MS in clinical toxicology testing, forensic analysis, urine drug testing, or pharmaceutical research. Lisdexamfetamine, a psychostimulant prodrug of dextroamphetamine, is marketed as the drug Vyvanse™ for treatment of attention deficit hyperactivity disorder (ADHD) in adults and children six to twelve years of age.
Specifications
| 67-56-1 | |
| UN 1230 - class 3 - PG 2 - Methanol, solution | |
| Lisdexamfetamine-D4 dimesylate solution | |
| Ampule | |
| 9.7°C (49.5°F) - closed cup |
| C15H21D4N3O · C2H6S2O6H2 | |
| 100 μg/mL in methanol (as free base) | |
| 459.61 | |
| 1 mL |
Safety and Handling
H331-H370
H311
EINECSNumber : 200-659-6
Recommended Storage : -20°C
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
CERILLIANT is a registered trademark of Cerilliant Corporation